Case Studies

Repositioning a Class-II device brand for regulated procurement

The Challenge

The client had built a strong reputation among private healthcare providers, but struggled to gain traction within regulated procurement channels. Despite offering clinically validated Class-II medical devices, procurement cycles remained long, fragmented, and heavily dependent on distributor relationships. The absence of a structured market positioning strategy meant procurement teams struggled to differentiate the brand from larger multinational competitors, resulting in inconsistent tender participation and low conversion across public and institutional healthcare networks.

The Approach

We began by analysing the client’s existing customer base, procurement history, and market positioning. Through a 4-week strategic assessment, we identified that their strongest growth opportunity was within regulated healthcare procurement networks, where purchasing decisions were driven by compliance, clinical evidence, and long-term supplier reliability rather than product features alone.

We mapped over 280 target healthcare organisations across the UK, GCC, and Southeast Asia, segmenting them by procurement framework, tender frequency, buying authority, and regulatory requirements.

Key findings from this phase:

  • 74% of previous institutional revenue came from repeat procurement contracts.
  • Average contract value within regulated healthcare organisations was 3.1x higher than private clinic sales.
  • Only 16% of target procurement stakeholders recognised the brand before active tender engagement.

Procurement Positioning Strategy

With the ideal procurement profile established, we rebuilt the brand around regulatory confidence, clinical credibility, and procurement readiness.

Procurement Messaging: Developed evidence-led positioning focused on regulatory compliance, clinical validation, quality certifications, and long-term procurement value, helping procurement teams evaluate the brand against established market leaders.

Healthcare Decision-Maker Programme: Built targeted campaigns for procurement managers, biomedical engineers, clinical directors, and hospital administrators through educational content, case studies, and compliance-focused communications.

Sales Enablement Layer: Equipped the commercial team with tender response templates, regulatory documentation, product comparison guides, and procurement-ready sales collateral, ensuring consistent messaging throughout lengthy evaluation cycles.

Procurement Engagement & Nurture

To maintain visibility throughout extended procurement cycles, we implemented a structured engagement programme designed to keep key stakeholders informed and engaged.

  • Clinical Insight Updates: Monthly thought leadership covering procurement regulations, healthcare industry trends, and clinical best practices, distributed to procurement and clinical decision-makers.
  • CRM Automation: Automated workflows tracking tender activity, document requests, stakeholder engagement, and follow-up reminders, enabling the sales team to respond proactively throughout the procurement journey.
58% Qualified procurement opportunities · 9 months
2.4 M Procurement pipeline generated
26 Hospital procurement teams engaged
The repositioning fundamentally changed how procurement teams perceived our brand. Instead of competing purely on price, we entered conversations as a clinically credible and procurement-ready partner. Our institutional pipeline is now stronger, more predictable, and built for long-term growth.
Commercial Director, Class-II Medical Device Manufacturer
Want the same results?

See how we'd architect your revenue system.

Share your sales motion — we'll send a tailored teardown and a 90-day acceleration map.